EGAGenomicsCancer Genomicshttps://ega-archive.org/studies/EGAS00001003553EGAEGA study EGAS00001003553To profile the landscape of sebaceous tumours_WESEGArestrictedWES.WASLBP, whole exome, Formol, DIP1, DNS, (Deoxyribonucleotide)n, Neoplasms, Benign Neoplasm, Tumor, Malignant, 54 kDa vimentin-interacting protein, extracted material, Deoxyribonucleic acids, Wasbp, Deoxyribonucleic Acid, Methanal, Parafilm, Whole Transcriptome, Transcriptome Sequencing, 90 kDa N-WASP-interacting protein, WES, thymus nucleic acid, Complete, Exome Sequencings, Malignancy, Complete Exome Sequencing, Whole Transcriptome Sequencing, Formaldehyd, Tissue, Oxomethane, Double Stranded, Deoxyribonucleic acid, Sequencing, Neoplasias, aggressive behaviour, Whole Exome, Formalin, malignant neoplasm, DIP, aggression, Whole, Malignancies, Double-Stranded DNA, (Deoxyribonucleotide)m, deoxyribonucleic acids, DNAn, Complete Exome., Cancer, Tumors, VIP54, Wiskott-Aldrich syndrome protein-interacting protein, Malignant Neoplasm, Complete Exome Sequencings, DNAn+1, WISH, Exome, Double-Stranded, AF3p21, (Deoxyribonucleotide)n+m, Exome Sequencing, MT, Benign, WASP-interacting SH3-domain protein, DIP-1, Neoplasm, sequence, FORMALIN, rare (European definition), ds-DNA, desoxyribose nucleic acid, Complete Transcriptome, primary cancer, Complete Transcriptome Sequencing, SH3 adapter protein SPIN90, N-WASP-binding protein, Exomes, Benign Neoplasms, Cancers, 90 kDa SH3 protein interacting with Nck, malignant tumor, primary structure of sequence macromolecule, Methylene oxide, Malignant Neoplasms, Oxomethylene, Wiskott-Aldrich syndrome protein-binding protein, ORF1, ds DNA, Whole Exome Sequencing, Desoxyribonukleinsaeure, SPIN90, DNA, Diaphanous protein-interacting protein, Transcriptome Sequencings, Neoplasia, Dia-interacting protein 1, AF3P21, 54 kDa VacA-interacting proteinfalseTo profile the landscape of sebaceous tumours WESSebaceous tumours are a rare cutaneous cancer with potential for aggressive behaviour. However, limited information is available on these cancers with few published cases. Here we wish to exome sequence these cancers to define the first genomic landscape for this malignancy. We will extract DNA from formalin-fixed, paraffin-embedded (FFPE) cores. Cores may be obtained from lesional and non-lesional tissues of primaries as well as matching metastases. The extracted DNA will be used for exome sequencing.2024-07-18 14:00:59EGAS000010035539606EGAD00001015367EGAC00001000205